DSIP Delta Sleep Inducing Peptide

Research Benefits

• Sleep Architecture Modulation — DSIP has been investigated for its role in promoting delta-wave (slow-wave) sleep stages in animal models, suggesting potential applications in sleep physiology research.
• Stress Response Regulation — Studies indicate DSIP may attenuate stress-induced corticotropin and cortisol elevations, making it a subject of interest in neuroendocrine stress research.
• Endocrine Interaction — Research demonstrates DSIP's influence on luteinizing hormone (LH) and growth hormone secretion patterns, pointing to broad hypothalamic-pituitary axis involvement.
• Antioxidant Properties — In vitro studies suggest DSIP may limit lipid peroxidation and enhance glutathione peroxidase activity under oxidative stress conditions.
• Opioid System Modulation — DSIP has shown interactions with the endogenous opioid system, with research exploring its potential to modulate pain perception pathways.

Mechanism of Action

Delta Sleep-Inducing Peptide (DSIP) is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from rabbit brain dialysates during induced slow-wave sleep. Its mechanism of action is multifactorial and not fully elucidated.

GABAergic Modulation: DSIP appears to enhance GABAergic transmission, the primary inhibitory neurotransmitter system in the central nervous system. This potentiation of GABA-A receptor-mediated signaling is hypothesized to underlie its sleep-promoting effects.

Neuroendocrine Effects: DSIP modulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing stress-induced cortisol release. It also influences LH pulsatility and somatotropin secretion, suggesting interaction with multiple hypothalamic releasing factors.

Serotonergic Interaction: Evidence suggests DSIP may influence serotonin (5-HT) metabolism in the brainstem raphe nuclei, contributing to its effects on sleep-wake cycling and circadian entrainment.

Oxidative Stress Defense: DSIP activates antioxidant enzyme systems, including superoxide dismutase and catalase, through mechanisms that may involve gene transcription regulation rather than direct enzyme activation.

Research Protocol

The following information is derived from published research literature and is intended for reference in research settings only.

Reconstitution

Reconstitute lyophilized DSIP with bacteriostatic water at a concentration suitable for the experimental model. Typical reconstitution yields 1 mg/mL solutions.

Research Dosing (from published studies)

• In vivo (rodent models): 10-100 mcg/kg administered intraperitoneally or intravenously.
• In vivo (larger animal models): 25 nmol/kg IV has been used in sleep architecture studies.
• Timing: Administration typically occurs during the early dark phase (active period) to assess effects on subsequent sleep cycles.

Experimental Duration

Acute studies range from single-dose to 5-day protocols. Chronic exposure studies have used 10-14 day administration periods with polysomnographic monitoring.

Storage

Store lyophilized peptide at -20°C. Reconstituted solutions should be refrigerated at 2-8°C and used within 14 days.

Safety & Handling

Research Use Only. This product is not intended for human or veterinary diagnostic or therapeutic use.

Storage Conditions

• Lyophilized: -20°C, protected from light and moisture
• Reconstituted: 2-8°C, use within 14 days
• Avoid repeated freeze-thaw cycles

Known Considerations from Literature

• DSIP has a relatively short plasma half-life (~7-8 minutes in rodent models), which may limit systemic bioavailability in certain experimental designs.
• No significant toxic effects have been reported at standard research doses in published animal studies.
• Potential interactions with GABAergic compounds (benzodiazepines, barbiturates) should be considered when designing combination studies.
• DSIP may influence glucocorticoid pathways; concurrent adrenal-axis investigations should account for this.

Handling

Use standard laboratory PPE including gloves and eye protection. Handle in a clean environment to prevent contamination. Dispose of unused material according to institutional biosafety guidelines.

Frequently Asked Questions

What is DSIP?

Delta Sleep-Inducing Peptide is a naturally occurring nonapeptide first isolated from cerebral venous blood during electrically induced sleep in rabbits. It consists of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) and is a subject of ongoing sleep and neuroendocrine research.

How should DSIP be stored?

Lyophilized DSIP should be stored at -20°C. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 14 days. Avoid repeated freeze-thaw cycles.

What purity is this product?

BeaCapra DSIP is manufactured to ≥99% purity as verified by HPLC analysis. A Certificate of Analysis (COA) is available for every batch.

What research areas involve DSIP?

DSIP is studied in sleep physiology, stress response, neuroendocrine regulation, oxidative stress, and opioid system modulation. It remains an active area of neuroscience research.

Is DSIP stable in solution?

DSIP has limited stability in aqueous solution due to enzymatic degradation. Reconstituted solutions should be used promptly and stored refrigerated. Some researchers use protease inhibitor cocktails to extend stability in vitro.